ArriVent BioPharma, Inc. Common Stock

AVBP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$29.64-0.60%

2026-08-03

Financials

Valuation Metrics

ArriVent BioPharma, Inc. Common Stock's Market Cap is $1.38B. At end of 2025 it was $774M. Ranked #2284 of 3,111 in US market (top 73%), #913 of 1,445 on NASDAQ (top 63%), #172 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 64%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.38B	US#2,284/3,111 Sec#172/269
Revenue	$0.00	US#2,980/3,111 Sec#205/269
Net Income	$-145M	US—/3,111 Sec—/269
Total Assets	$349M	US#2,871/3,111 Sec#196/269
Net Assets	$324M	US#2,516/3,111 Sec#154/269
Value
P/B	4.26x	US#2,059/3,111 Sec#127/269
FCF Yield	-9.74%	US—/3,111 Sec—/269
Profitability
ROE	-44.83%	US#2,720/3,111 Sec#164/269
ROA	-41.58%	US#2,942/3,111 Sec#197/269
Financial Health
Debt Ratio	7.81%	US#81/3,111 Sec#38/269
Total Debt	$419000.00	US#2,982/3,111 Sec#261/269
FCF	$-134M	US#2,666/3,111 Sec#180/269
Cash	$62M	US#2,497/3,111 Sec#216/269
Current Ratio	13.95x	US#172/3,111 Sec#59/269
Performance
1Y Return	58.84%	US#674/3,111 Sec#122/269
1M Return	-14.51%	US#2,637/3,111 Sec#205/269
From 52W High	-17.28%	US#1,454/3,111 Sec#97/269
1Y MDD	-33.32%	US#1,595/3,111 Sec#103/269
Trading
Volume	267,249 shares	US#2,155/3,111 Sec#214/269
Trading Value	$8M	US#2,173/3,111 Sec#173/269
Per Share
EPS	$-4.32	US—/3,111 Sec—/269
BPS	$7.99	US#1,945/3,111 Sec#86/269